
Porencephaly: Unraveling Mysteries with Genetic Testing
Genetic testing unveils porencephaly causes, aiding diagnosis, treatment, and research. Explore mutations, early detection, and personalized management strategies.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Genetic testing unveils porencephaly causes, aiding diagnosis, treatment, and research. Explore mutations, early detection, and personalized management strategies.

Cilia lining the airways lose normal motion in PCD, causing repeated infections and nasal congestion; splice-site changes in DNAH5 and their detection are explained.

Cowden, Bannayan-Riley-Ruvalcaba and Proteus syndromes all fall under PHTS, which stems from PTEN mutations; testing confirms it and flags relatives at risk.

Underdeveloped renal tubules leave newborns unable to balance fluid and electrolytes; this autosomal recessive disorder involves renin-angiotensin system genes.

Pathogenic variants in SMARCB1 are linked to aggressive rhabdoid tumors of the brain, kidneys and soft tissues, usually in infancy. Relatives can be tested as well.

Usually benign and often sited in the fourth ventricle, these tumors mainly affect young adults. Genetic profiling helps separate them from DNETs and informs prognosis.

Reddish patches, atrophy and telangiectasia appear with growth retardation and skeletal problems in this recessive disorder. Testing supports surveillance plans.

RECQL4 mutations affect DNA replication and repair, producing poikiloderma, sparse hair, small stature and a raised osteosarcoma risk that clinicians can monitor.